For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.

Notice of Blackbaud Incident.

Decorative dot pattern background image.
Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image. Decorative blue shape background image.

Clinical Trials Search

As a clinical trial candidate at Methodist, you’re offered unique access to new drugs and technology being studied to improve patient outcomes.
Filter by Disease or Condition
Showing 1-10 results of 22
Lung Cancer

AbbVie M19-700

Official Title: A Phase 1B Study Of Venetoclax In Combination With Pembrolizumab In Subjects With Previously Untreated Non-Small Cell Lung Cancer Whose Tumors Have High PD-L1 Expression
Study Purpose: To determine the safe and tolerable dose of venetoclax in combination with pembrolizumab.
Status: Suspended
Lung Cancer

Alliance A081801

Official Title: Testing The Addition Of A Type Of Drug Called Immunotherapy To The Usual Chemotherapy Treatment For Non-Small Cell Lung Cancer
Study Purpose: To compare the usual treatment alone to using pembrolizumab plus the usual treatment.  The addition of pembrolizumab to the usual treatment could prevent it from returning.
Status: Recruiting
Lung Cancer

Alliance A151216

Official Title: Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Study Purpose: To study the genes of tumor cells to determine if these results will help physicians select the best treatment options for patients with genetic changes. 
Status: Recruiting
Lung Cancer

Alliance A171901

Official Title: Testing the effects of mk-3475 (pembrolizumab) with or without the usual chemotherapy treatment for patients 70 years of age and older with advanced non-small cell lung cancer.
Study Purpose: To find out if patients aged 70 years or older have different side effects than younger patients from treatment with the usual approach for non-small cell lung cancer.
Status: Recruiting
Lung Cancer

AstraZeneca D4194C00008

Official Title: Prospective, Interventional Pilot Study Of Mobile Devices And Digital Applications To Detect Early Pneumonitis And Other Pulmonary Adverse Events In Unresectable Stage Iii Non-Small Cell Lung Cancer Patients On Durvalumab
Study Purpose: To test new technology that monitors your respiratory function data, oxygen saturation levels, vital signs, and physical movement data without affecting your daily life in a significant way.
Status: Recruiting
Lung Cancer

Biodesix, Inc. BDX-00146

Official Title: An observational study assessing the clinical effectiveness of the VeriStrat test and validation immunotherapy tests in subjects with non-small cell lung cancer
Study Purpose: To collect information about how the study doctor uses the results of the VeriStrat blood test to choose treatment for NSCLC.
Status: Recruiting
Lung Cancer

Calithera Biosciences CX-839-014

Official Title: A Phase 2 Randomized, Multicenter, Double-Blind Study Of The Glutaminase Inhibitor Telaglenastat With Pembrolizumab And Chemotherapy Versus Placebo With Pembrolizumab And Chemotherapy In First-Line, Metastatic KEAP1/NRF2-Mutated, Non-Squamous, Non-Small Cell Lung Cancer (NSCLC)
Study Purpose: To determine the amount of telaglenastat that is safe and tolerable when given together with the recommended treatment regimen of pembrolizumab, carboplatin, and pemetrexed and to determine if the combination of standard drugs with telaglenastat is more active against your type of cancer than the standard drugs alone.
Status: Recruiting
Lung Cancer

CTSU E4512

Official Title: A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Study Purpose: To compare any good and bad effects of using the study drug, crizotinib, after completion of surgery and, in some cases, after chemotherapy and/or radiation therapy for ALK-positive non-small cell lung cancer.
Status: Recruiting
Lung Cancer

CTSU LungMAP

Official Title: Targeted Treatment for Advanced Non-small Cell Lung Cancer
Study Purpose: To find out if a targeted or immunotherapy treatment will have an effect on specific genes and proteins in the tumor.
Status: Recruiting
Lung Cancer

CTSU S1827

Official Title: Testing Whether the Of Brain Scans Alone Instead Of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients with Small Cell Lung Cancer
Study Purpose: To see if the use of brain scans alone instead of brain scans plus preventive brain radiation affect the lifespan of patients with small cell lung cancer.
Status: Recruiting